EDBI Logo
|  

MerLion’s Finafloxacin Shown to be More Efficacious than Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections

MerLion’s Finafloxacin Shown to be More Efficacious than Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections

Related Posts

Forging Resilience in Both Worlds

  • 29 02 2024
  • |
Read More

The Harvard Founder Who Did the Opposite of What He Learnt

  • 29 02 2024
  • |
Read More

Bounce Back Stronger: 4 Ways to Turn Failure into Fuel for Success

  • 29 02 2024
  • |
Read More

Silicon Valley doesn’t have all the Answers

  • 29 02 2024
  • |
Read More

From Burning to Turning to Earning. The Inside Story of a Business Resurrection.

  • 29 02 2024
  • |
Read More

EDBI: A look back at 2023

  • 16 02 2024
  • |
Read More

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

Linkedin Youtube

© 2023 EDBI. All rights reserved.